HERNEXEOS (ZONGERTINIB 60 MG TAB )
Price
FAQ's
Details
Patients Stories
Important Guide
Zongertinib is an oral, selective HER2 tyrosine kinase inhibitor developed for the treatment of HER2-mutant non-small cell lung cancer (NSCLC). By targeting abnormal HER2 signaling, it helps inhibit tumor growth and may improve outcomes in patients with HER2-driven cancers.

